Details for Patent: 10,300,041

« Back to Dashboard

Which drugs does patent 10,300,041 protect, and when does it expire?

Patent 10,300,041 protects FLOLIPID and is included in one NDA.

This patent has twelve patent family members in twelve countries.

Summary for Patent: 10,300,041

Title:	Liquid oral simvastatin compositions
Abstract:	Aqueous suspensions for oral administration are disclosed that include simvastatin having a d90 of simvastatin particles of less than about 100 μm as the active agent. The aqueous suspension also includes simvastatin as about 20 mg to about 80 mg per 5 ml of the aqueous suspension, a suspending agent as about 20 mg to about 50 mg of the aqueous suspension, a wetting agent, an antimicrobial preservative, an antifoaming agent, water, and a buffering system providing the aqueous suspension with a pH of about 6.4 to about 7. Methods of making such a suspension and methods of treatments in orally administering the same are also disclosed.
Inventor(s):	Phillip Driver
Assignee:	Rosemont Pharmaceuticals Ltd
Application Number:	US15/423,710
Patent Claim Types: see list of patent claims	Compound; Dosage form;

Drugs Protected by US Patent 10,300,041

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Salerno Pharms	FLOLIPID	simvastatin	SUSPENSION;ORAL	206679-001	Apr 21, 2016		RX	Yes	No			Y
Salerno Pharms	FLOLIPID	simvastatin	SUSPENSION;ORAL	206679-002	Apr 21, 2016		RX	Yes	Yes			Y

International Family Members for US Patent 10,300,041

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	E552825
Australia	2007245410
China	101431982
Cyprus	1112917
Denmark	2018153
European Patent Office	2018153
Spain	2385752